CHRISTOPHER BYRNE: Open Payments
NPI 1306846415 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,038 in 234 payments from 23 companies in 2025. Trend: 2023 $9,026 · 2024 $3,929 · 2025 $4,038
Food & beverage: $3,969Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $781 |
| Janssen Biotech, Inc. | 45 | $754 |
| Novartis Pharmaceuticals Corporation | 30 | $452 |
| LEO Pharma Inc. | 18 | $303 |
| UCB, Inc. | 16 | $287 |
| GENZYME CORPORATION | 10 | $254 |
| Incyte Corporation | 13 | $242 |
| Organon LLC | 9 | $197 |
| Arcutis Biotherapeutics, Inc. | 7 | $155 |
| Lilly USA, LLC | 4 | $81 |
Products named: TREMFYA, SKYRIZI, COSENTYX, DUPIXENT, Bimzelx, OPZELURA, RINVOQ, ADBRY.
Industry payments across NY — which companies pay providers there.
